NCT07183410

Brief Summary

Taking blood cultures is an important and very common procedure in intensive care units due to the high incidence of sepsis and the need for rapid and accurate identification of bacteremia. However, despite the importance of taking a sufficient volume of blood for the purpose of identifying bacterial growth in the blood, the average blood volume in blood cultures at our institution ranges from 3.5-4 ml per bottle (where the desired volume is 10 ml). Taking an insufficient amount of blood reduces the ability of the bacteriological laboratory to detect bacterial growth and thus may lead to a delay or missed diagnosis of bacteremia, identification of the pathogen, and adjustment of appropriate treatment according to sensitivities. In intensive care units, most patients are monitored using an arterial catheter, which allows for frequent blood tests without the need to puncture the patient. Following recently published studies that showed that there is no significant difference in the incidence of contamination when taking blood cultures from an arterial catheter compared to a peripheral vein puncture, and in order to improve our ability to identify bacteremia, it was decided to implement a new protocol in the General Intensive Care Unit that includes taking blood cultures from an arterial catheter. According to the new protocol, it was decided that when taking blood cultures from a patient with an arterial catheter, one pair of cultures should be taken from the arterial catheter and another pair from a peripheral vein puncture. In this study, we would like to examine the contamination rate of blood cultures, the identification of true bacteremia, and the collection of appropriate blood volume and number of blood specimens taken in patients hospitalized in the General Intensive Care Unit at our institution, while analyzing differences between the period before the implementation of the new protocol and the period after the implementation, and differences between cultures taken from an arterial catheter and from a peripheral vein puncture.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
25mo left

Started Jan 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Jan 2026Jun 2028

First Submitted

Initial submission to the registry

September 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 19, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

September 14, 2025

Last Update Submit

September 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Contamination and real bacteremia detection rates

    To examine whether there are differences between the contamination rate and the detection rate of true bacteremia between blood cultures from an arterial catheter and blood cultures from a fresh puncture of a peripheral vein.

    One week following blood cultures collection

Study Arms (2)

Cultures from arterial line

From each patient enrolled in the study, two sets of blood cultures will be drawn: one set (2 bottles) from an arterial line and one set from peripheral venous puncture. Each patient will be both the study and the control group for himself: The comparison will be between the arterial line vs. the peripheral vein puncture set. In addition, we will also perform a before and after intervention analysis- to examine whether the implementation of the new protocol improved the rate of appropriate blood culture volume and number of culture drawn from the patient .

Diagnostic Test: Blood culture taken from an arterial catheter

Cultures from peripheral venous puncture

From each patient enrolled in the study, two sets of blood cultures will be drawn: one set (2 bottles) from an arterial line and one set from peripheral venous puncture. Each patient will be both the study and the control group for himself: The comparison will be between the arterial line vs. the peripheral vein puncture set. In addition, we will also perform a before and after intervention analysis- to examine whether the implementation of the new protocol improved the rate of appropriate blood culture volume and number of culture drawn from the patient .

Interventions

Blood culture taken from an arterial catheter (instead of peripheral venous puncture)

Cultures from arterial line

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted to the intensive care unit in our hospital between January 2024 and January 2027 who had blood cultures taken as part of their routine care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Medical Center

Kfar Saba, Israel

Location

MeSH Terms

Conditions

Bacteremia

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

September 14, 2025

First Posted

September 19, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

September 19, 2025

Record last verified: 2025-09

Locations